Skip to main content

The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains.

Gutala RV, Reddy PH

Publication: J Neurosci Methods (2004) • Vol 132 • Page 101PMID: 14687679View on PubMed

Purpose

The purpose of this paper was to assess the influence of postmortem interval, brain weight, patient age, and diagnosis of Alzheimer's disease on real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) amplification of beta-actin, 18S, and GAPDH RNA.

Conclusion

The authors report that postmortem interval (up to 24 hours), age at death, brain weight, and diagnosis had no effect on success of qRT-PCR. However, they report caution in using 18S or beta-actin RNA for normalization as these were differentially expressed in Alzheimer's and age-matched control brains; GAPDH did not show this differential expression, thus the authors conclude that it is a reasonable choice for normalization.

Studies (1)

Purpose

The purpose of this study was to assess the influence of postmortem interval, brain weight, patient age, and diagnosis of Alzheimer's disease on real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) amplification of beta-actin, 18S, and GAPDH RNA.

Summary of Findings

The authors report that postmortem interval (up to 24 hours), age at death, brain weight, and diagnosis had no effect on success of qRT-PCR. However, they report caution in using 18S or beta-actin RNA for normalization as these were differentially expressed in Alzheimer's and age-matched control brains; GAPDH did not show this differential expression, thus the authors conclude that it is a reasonable choice for normalization.
  • Biospecimens

    TissueBrain
  • Preservation Types

    Frozen
  • Diagnoses

    Alzheimer's Disease
    Not specified
    Autopsy
  • Platforms

    RNAReal-time qRT-PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Alzheimer's disease
    No diagnosis of dementia
    PreaquisitionPatient age
    67 - 92 years
    PreaquisitionPostmortem interval
    7 - 24 h
    Biospecimen AcquisitionOrgan measurements
    1020 - 1700 g
    Real-time qRT-PCR SpecificTargeted nucleic acid
    18S RNA
    GAPDH
    beta-actin